NW-1689
NW-1689 is a process-related impurity of safinamide mesilate (SAFM), which is a medication used in the treatment of Parkinson's disease (PD) . SAFM acts as a highly selective and reversible inhibitor of monoamine oxidase-B (MAO-B) and also blocks sodium and N-type calcium channels. These actions assist in reducing dopamine breakdown and suppressing glutamate release. NW-1689 shares structural similarities with SAFM and exhibits comparable pharmacological effects, making it applicable in Parkinson's disease research.
Product Specifications
CAS Number
405-85-6
Smiles
O=C (O) C1=CC=C (OCC=2C=CC=C (F) C2) C=C1
Molecular Formula
C14H11FO3
Molecular Weight
246.23
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A03263-2-APC 100 µg/Vial
Anti-TEF1/TEAD-1/TEAD1 Antibody Picoband®, APC Conjugate
Sign In for Pricing
View Details 
GTR15137937 1 Vial
Lentiviral human APOD shRNA (UAS) - Lentiviral human APOD shRNA (UAS, GFP) (100)
Sign In for Pricing
View Details